We critically reviewed every NICU blood component transfusion (packed erythrocytes, platelets, frozen plasma (FP) and cryoprecipitate) administered during a one-year period. This was done to determine ...

The addition of early and empirical high-dose cryoprecipitate to usual care does not improve clinical outcomes in patients with trauma and bleeding who required activation of a major hemorrhage ...

Dr. Cushing will discuss the critical role of rapid cryoprecipitate transfusion in treating coagulopathy in bleeding patients. Dr. Susan Stramer, Vice President, Scientific Affairs, Biomedical ...

TPE for TTP is a highly effective therapy, but it requires repeated exposures to large volumes of plasma or cryoprecipitate-poor plasma. Pathogen reduced cryoprecipitate-poor plasma offers the ...

Two newer approaches to management of major hemorrhage missed the mark in randomized clinical trials published in a special transfusion-related issue of JAMA. In the CRYOSTAT-2 trial, adding early, ...

Plasma from whole blood donations or apheresis is used to either prepare plasma components for clinical transfusion or fractionate to produce pure plasma proteins. Cryoprecipitate is produced by ...

HOBOKEN, N.J. (November 5, 2019) - Octapharma USA sponsored a scientific symposium, "Fibrinogen Supplementation in Surgical Patients - New Perspectives in Acquired Fibrinogen Deficiency," at the ...

Addressing hemophiliac patients, at a one-day open clinic for their effective treatment and management, Professor Neelam Marwaha, head of Department of Transfusion Medicine, PGIMER, organized by the ...

People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...